PLATFORM SUGAR MONITORING TECHNOLOGY
At Ziylo we are developing the world’s most selective, robust and versatile Glucose Binding Molecules (GBMs). Ziylo is currently working with partners to utilise these patented GBMs to create a platform technology for Continuous Glucose Monitoring (CGM) in biopharmaceutical process control. Our long-term mission is to develop the next generation of precise and reliable sensors for use in blood CGM for diabetics. We are actively looking for suitable partners to deliver this objective.